Patent details

Basic Information

Publication number:

EP1663170

PCT Application Number:

PCT/US/2004/004112

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP047106562

PCT Publication Number:

WO/2005/039540

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NOVEL PHARMACEUTICAL FORMULATION CONTAINING A BIGUANIDE AND A THIAZOLIDINEDIONE DERIVATIVE

French Title of Invention:

NOUVELLE PREPARATION PHARMACEUTIQUE CONTENANT UN BIGUANIDE ET UN DERIVE THIAZOLIDINEDIONE

German Title of Invention:

NEUE PHARMAZEUTISCHE FORMULIERUNG MIT EINEM BIGUANID UND EINEM THIAZOLIDINDION-DERIVAT

SPC Number:

Dates

Filing date:

12/02/2004

Grant date:

24/06/2015

EP Publication Date:

24/06/2015

PCT Publication Date:

06/05/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/06/2006

EP B1 Publication Date:

24/06/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/02/2016

Expiration date:

12/02/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/02/2004

 

 

Name:

Andrx Labs LLC

Address:

4955 Orange Drive, Davie, FL 33314, United States (US)

Inventor

1

Name:

NANGIA Avinash

Address:

United States (US)

2

Name:

LODIN Unchalee

Address:

United States (US)

3

Name:

CARDINAL John

Address:

United States (US)

4

Name:

GOLDFARB Robert, I.

Address:

United States (US)

Priority

Priority Number:

664803

Priority Date:

19/09/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/28;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages